Rapid risk assessment: Outbreak of Rift Valley fever in Niger, 10 October 2016
This rapid risk assessment monitors the threat posed by Rift Valley fever (RVF) which has been reported in regions of eastern and southern Africa, and in most of the sub-Saharan and West African countries.
Severe respiratory disease associated with Middle East respiratory syndrome coronavirus - 21st update, 21 October 2015
This 21st update of ECDC’s risk assessment on MERS-CoV has been triggered by an increase in MERS cases acquired through nosocomial transmission in Amman, Jordan.
Rapid Risk Assessment: Outbreak of circulating vaccine-derived poliovirus type 1 in Ukraine, 4 September 2015
This risk assessment was triggered by two cases of paralytic poliomyelitis in children, caused by circulating vaccine-derived poliovirus type 1 (cVDPV1) in Ukraine during June and July 2015.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Eleventh update, 21 August 2014
This eleventh updated rapid risk assessment on MERS-CoV shows that the number of cases has been steadily declining in the last few months.
Risk of introduction and transmission of wild-type poliovirus in EU/EEA countries following events in Israel and Syria – updated risk assessment (9 December 2013)
The confirmed circulation of wild-type poliovirus (WPV) in Israel and the outbreak of poliomyelitis in Syria mean that there is a high risk the disease will be reintroduced into the EU/EEA.
Suspected outbreak of poliomyelitis in Syria: Risk of importation and spread of poliovirus in the EU
Following the announcement by WHO of a cluster of cases of acute flaccid paralysis in Syria, ECDC conducted a risk assessment and concludes that this does pose a risk that polio might be imported to the EU. The Risk Assessment includes number of recommendations for EU Member States.
Risk assessment: Wild-type poliovirus 1 transmission in Israel – what is the risk to Europe?
The EU/EEA countries and the rest of the WHO European Region, have been officially polio-free since 2002. However, wild-type polio virus 1 (WPV1) has been isolated in sewage and in the faeces of asymptomatic carriers in Israel since February 2013. In this risk assessment ECDC looks at the potential impact of this public health event on the risk of poliovirus being imported and re-established into circulation in EU/EEA.
Outbreak of hepatitis A virus infection in travellers returning from Egypt
Between 1 November 2012 and 30 April 2013, 15 confirmed cases of hepatitis A virus infections with subgenotype IB and identical RNA sequence, and 89 probable cases, have been reported in 14 EU/EFTA countries. All cases have a travel history to Egypt.
Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
Outbreak of measles in Ukraine and potential for spread in the EU, 2012
A rapid risk assement on the risk of measles for visitors to Ukraine, particularly during the UEFA European Football Championship, EURO 2012, and the potential spread of infection within the EU.